Ignite Creation Date:
2025-12-24 @ 10:59 PM
Ignite Modification Date:
2026-01-01 @ 6:28 PM
Study NCT ID:
NCT07030569
Status:
RECRUITING
Last Update Posted:
2025-06-22
First Post:
2025-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study
Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2027-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-07
First Submit QC Date:
None
Study First Post Date:
2025-06-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-12
Last Update Post Date:
2025-06-22
Last Update Post Date Type:
ACTUAL